Showing results (201-210 of 238) with videos related to

Sort By:
Pageof 24
BMJ Mental Health|September 15, 2023
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients' primary care records in situ using OpenSAFELYOrla Macdonald, Amelia Green, Alex Walker, et al.
British Journal of Clinical Pharmacology|April 8, 2024
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rateAndrew D Brown, Louis Fisher, Helen J Curtis, et al.
BMJ Open|January 31, 2023
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study, Edward Pk Parker, John Tazare, et al.
The Lancet. HIV|December 14, 2020
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platformKrishnan Bhaskaran, Christopher T Rentsch, Brian MacKenna, et al.
Open Heart|November 17, 2021
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic, Helen J Curtis, Brian MacKenna, et al.
The Lancet Regional Health. Europe|May 17, 2021
Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platformKrishnan Bhaskaran, Sebastian Bacon, Stephen Jw Evans, et al.
Nature|July 9, 2020
Factors associated with COVID-19-related death using OpenSAFELYElizabeth J Williamson, Alex J Walker, Krishnan Bhaskaran, et al.
BMJ Medicine|May 28, 2024
Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak: retrospective cohort study in England using OpenSAFELY-TPPChristine Cunningham, Louis Fisher, Christopher Wood, et al.
British Journal of Clinical Pharmacology|March 26, 2024
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records, Christopher Wood, Victoria Speed, et al.
Annals of the Rheumatic Diseases|January 22, 2021
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohortsAngel Ys Wong, Brian MacKenna, Caroline E Morton, et al.
Pageof 24